BIO-TECHNE TO PRESENT AT THE 2024 AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) CONFERENCE
Several scientists from the company will be presenting posters at the conference highlighting our in-house studies in the areas of drug discovery research, automated spatial multiomics, and the development of novel diagnostic tools. These include investigations into validating atypical drug combinations, analyzing the tumor microenvironment by integrated RNA and protein profiling with automated spatial multiomics, developing an exosome/cfDNA methylation blood-based screen for colorectal cancer, and monitoring ESR1 mutations by RT-qPCR in longitudinal studies to predict endocrine therapy resistance.
"We are excited to showcase our portfolio of innovative tools, reagents and workflow solutions that enable the scientific discoveries necessary to advance cancer research," said
Bio-Techne Poster Presentations:
Validation of Atypical Drug Combinations Identified from Combination Databases
Presenter:
Poster Section #39, Poster Board #11, Abstract #943
Unveiling the Spatial Dynamics of the Tumor Microenvironment: Integrated RNA and Protein Profiling on the Same Slide through Automated Spatial Multiomics Analysis
Presenter:
Poster Section #45, Poster Board #20, Abstract #3797
A Kit Targeting Detection of ESR1 Mutations from Circulating Exosomal RNA and Cell-Free DNA Supports Longitudinal Studies into Endocrine Therapy Resistance in a Broadly Accessible RT-qPCR Format
Presenter:
Poster Section #26, Poster Board #2, Abstract #4626
Exosome Based Multiomics Combined with cfDNA Methylation Reveals Complementary Signatures in Blood Based Liquid Biopsy that Carry Promise for Minimally Invasive Colorectal Cancer Screening
Presenter:
Poster Section #51, Poster Board #10, Abstract #LB393
Poster Presentation, In Collaboration
Bladder Cancer Risk Stratification with the Oncuria 10 plex Bead-based Urinalysis Assay Using Three Different Luminex® xMAP Instrumentation Platforms
Presenter:
Poster Section #44, Poster Board #29, Abstract #3773
About
About
Contact:
david.clair@bio-techne.com
612-656-4416
View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-present-at-the-2024-american-association-for-cancer-research-aacr-conference-302104522.html
SOURCE